EP Patent

EP2647634A1 — Indole-pyrimidine derivatives and their therapeutic uses

Assigned to Noscira SA · Expires 2013-10-09 · 13y expired

What this patent protects

The present invention relates to new indole-pyrimidine derivatives of Formula (I), a process for obtaining them, a pharmaceutical composition comprising said compounds and their use in the treatment of several disease including cognitive, neurodegenerative or neurological disease…

USPTO Abstract

The present invention relates to new indole-pyrimidine derivatives of Formula (I), a process for obtaining them, a pharmaceutical composition comprising said compounds and their use in the treatment of several disease including cognitive, neurodegenerative or neurological diseases or conditions, diabetes, inflammatory and autoimmune diseases and cardiovascular disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2647634A1
Jurisdiction
EP
Classification
—
Expires
2013-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Noscira SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.